Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

The government may consider a nationwide ban on the widely used antacid ranitidine after an expert committee reportedly submitted a detailed report highlighting its potential cancer risks. According ...

The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

Experts at the US Federal Court state that links between the Ranitidine and cancer (which include lung, liver, and kidney cancer) are illegitimate. District court in Florida has dismissed almost ...

But, the studies reporting an association between ranitidine and cancer development used self-report or cross-sectional data, and did not consider the other health conditions of their subjects (22, 30 ...

Despite concerns about cancer-causing agents in Ranitidine and an expert panel's recommendation to suspend it, India's drug advisory body has decided to form another committee to investigate. Previous ...

Ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists (H 2 RAs), according to a study published in JAMA Network Open. 2 RAs), according to a ...

Credit: Getty Images. A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists. Ranitidine does not pose an ...